Published in J Med Econ on January 01, 2009
Epidemiology and management of common pulmonary diseases in older persons. J Gerontol A Biol Sci Med Sci (2012) 0.95
Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2010) 0.87
Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009. Int J Chron Obstruct Pulmon Dis (2011) 0.80
Clinical and economic outcomes for patients initiating fluticasone propionate/salmeterol combination therapy (250/50 mcg) versus anticholinergics in a comorbid COPD/depression population. Int J Chron Obstruct Pulmon Dis (2012) 0.78
Cost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive pulmonary disease in the UK. Cost Eff Resour Alloc (2015) 0.77
COPD a social disease: inappropriateness and pharmaco-economics. The role of the specialist: present and future. Multidiscip Respir Med (2010) 0.75
Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest (2007) 4.96
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N Engl J Med (2015) 4.16
The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med (2005) 2.34
Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care (2006) 2.28
New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whites. Am J Respir Crit Care Med (2011) 2.07
Burden of concomitant asthma and COPD in a Medicaid population. Chest (2008) 1.87
Spirometry and health status worsen with weight gain in obese smokers but improve in normal-weight smokers. Am J Respir Crit Care Med (2014) 1.77
Effect of exposure to evidence-based pharmacotherapy on outcomes after acute myocardial infarction in older adults. J Am Geriatr Soc (2012) 1.58
Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med (2014) 1.52
Coverage and use of prescription drugs in nursing homes: implications for the medicare modernization act. Med Care (2006) 1.46
Age and sex trends in long-term opioid use in two large American health systems between 2000 and 2005. Pain Med (2009) 1.38
Treatment of dementia in community-dwelling and institutionalized medicare beneficiaries. J Am Geriatr Soc (2007) 1.32
Assessing the impact of coverage gaps in the Medicare Part D drug benefit. Health Aff (Millwood) (2006) 1.32
Potential benefits and problems with computerized prescriber order entry: analysis of a voluntary medication error-reporting database. Am J Health Syst Pharm (2006) 1.29
A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population. Int J Psychiatry Med (2004) 1.24
Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population. Arch Intern Med (2005) 1.24
Quality of psychopharmacological medication prescribing and mortality in Medicare beneficiaries in nursing homes. J Am Geriatr Soc (2014) 1.22
Wood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokers. Am J Respir Crit Care Med (2010) 1.10
An algorithm for the identification of undiagnosed COPD cases using administrative claims data. J Manag Care Pharm (2006) 1.09
Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diabetes Care (2009) 1.07
Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease. Am J Manag Care (2008) 1.06
Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims. Int J Chron Obstruct Pulmon Dis (2011) 1.02
Effects of state surveillance on new post-hospitalization benzodiazepine use. Int J Qual Health Care (2003) 1.01
Evaluation of nationally mandated drug use reviews to improve patient safety in nursing homes: a natural experiment. J Am Geriatr Soc (2005) 1.01
Inappropriate drug use and risk of transition to nursing homes among community-dwelling older adults. Med Care (2006) 1.00
Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting. Appl Health Econ Health Policy (2014) 0.98
Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies. Curr Med Res Opin (2009) 0.96
Racial and ethnic disparities in the treatment of dementia among Medicare beneficiaries. J Gerontol B Psychol Sci Soc Sci (2008) 0.96
Adherence to controller therapy for chronic obstructive pulmonary disease: a review. Curr Med Res Opin (2010) 0.96
Economic burden prior to COPD diagnosis: a matched case-control study in the United States. Respir Med (2008) 0.95
A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging population. Ann Epidemiol (2008) 0.94
Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage. Health Serv Res (2008) 0.94
How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction. Health Serv Res (2013) 0.93
Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen. Clin Ther (2007) 0.93
Lack of relationship between long-term use of benzodiazepines and escalation to high dosages. Psychiatr Serv (2003) 0.93
Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J Gen Intern Med (2010) 0.93
Impact of maintenance therapy on hospitalization and expenditures for Medicare beneficiaries with chronic obstructive pulmonary disease. Am J Geriatr Pharmacother (2010) 0.92
The positive predictive value of a hyperkalemia diagnosis in automated health care data. Pharmacoepidemiol Drug Saf (2010) 0.92
Pharmacotherapeutic management of dementia across settings of care. J Am Geriatr Soc (2013) 0.92
Racial disparities in access after regulatory surveillance of benzodiazepines. Arch Intern Med (2006) 0.90
Benzodiazepine use and expenditures for Medicare beneficiaries and the implications of Medicare Part D exclusions. Psychiatr Serv (2008) 0.89
Changing patterns in medication use with increasing probability of death for older Medicare beneficiaries. J Am Geriatr Soc (2010) 0.88
An elective psychiatric course to reduce pharmacy students' social distance toward people with severe mental illness. Am J Pharm Educ (2011) 0.87
Methylated Genes in Sputum Among Older Smokers With Asthma. Chest (2012) 0.87
Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2010) 0.87
Can outpatient pharmacy data identify persons with undiagnosed COPD? Am J Manag Care (2010) 0.87
Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease. J Am Geriatr Soc (2013) 0.87
Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry (2013) 0.87
Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD management. J Med Econ (2011) 0.86
The effect of a three-tier formulary on antidepressant utilization and expenditures. J Ment Health Policy Econ (2008) 0.85
Prevalence of Bartonella infection in domestic cats in Denmark. Vet Res (2002) 0.85
Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). Am J Cardiol (2008) 0.84
Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults. Am J Geriatr Pharmacother (2008) 0.84
Cost and resource utilization associated with fluconazole as first-line therapy for invasive candidiasis: a retrospective database analysis. Clin Ther (2010) 0.84
Increasingly restrictive definitions of hyperkalemia outcomes in a database study: effect on incidence estimates. Pharmacoepidemiol Drug Saf (2010) 0.84
Treatment patterns of chronic obstructive pulmonary disease in employed adults in the United States. Int J Chron Obstruct Pulmon Dis (2015) 0.84
US trends in glycemic control, treatment, and comorbidity burden in patients with diabetes. J Clin Hypertens (Greenwich) (2010) 0.83
Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities. Am J Geriatr Pharmacother (2009) 0.82
Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes. Med Care (2012) 0.82
Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States. J Asthma (2010) 0.82
Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans. Med Care (2011) 0.82
Increased methylation of lung cancer-associated genes in sputum DNA of former smokers with chronic mucous hypersecretion. Respir Res (2014) 0.82
Increases in opioid medication use: balancing the good with the bad. Pain (2008) 0.82
Economic burden of chronic bronchitis in the United States: a retrospective case-control study. Int J Chron Obstruct Pulmon Dis (2011) 0.82
Assessing disparities in the receipt of inhaled corticosteroid prescriptions for asthma by Hispanic and non-Hispanic white patients. Ann Am Thorac Soc (2015) 0.81
Latent variable mixture modeling: a flexible statistical approach for identifying and classifying heterogeneity. Nurs Res (2012) 0.81
Health care use in depressed, elderly, cardiac patients and the effect of antidepressant use. Am J Health Syst Pharm (2009) 0.81
A genome-wide association study of chronic obstructive pulmonary disease in Hispanics. Ann Am Thorac Soc (2015) 0.81
Increased Rates of Mild Traumatic Brain Injury Among Older Adults in US Emergency Departments, 2009-2010. J Head Trauma Rehabil (2016) 0.81
Antiparkinson drug use and adherence in medicare part D beneficiaries with Parkinson's disease. Clin Ther (2013) 0.79
Effect of medications on physical function and cognition in nursing home residents with dementia. J Am Geriatr Soc (2014) 0.79
Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population. Curr Med Res Opin (2009) 0.79
Development of a modified BODE index as a mortality risk measure among older adults with and without chronic obstructive pulmonary disease. Am J Epidemiol (2013) 0.79
Features indicative of cervical abnormality. A factor to be reckoned with in clinical headache work and research? Funct Neurol (2004) 0.79
The role of combination inhaled corticosteroid/long-acting beta-agonist therapy in COPD management. Prim Care Respir J (2010) 0.79
Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population. Am J Geriatr Pharmacother (2012) 0.78
Obesity status and colorectal cancer screening in the United States. J Obes (2013) 0.78
Use of drugs with anticholinergic properties among nursing home residents with dementia: a national analysis of Medicare beneficiaries from 2007 to 2008. Drugs Aging (2015) 0.78
Algorithm for Identifying Nursing Home Days Using Medicare Claims and Minimum Data Set Assessment Data. Med Care (2016) 0.78
Cost-effectiveness of combination fluticasone propionate-salmeterol 250/50 microg versus salmeterol in severe COPD patients. Int J Chron Obstruct Pulmon Dis (2010) 0.77
Chronic Bronchitis Is Associated With Worse Symptoms and Quality of Life Than Chronic Airflow Obstruction. Chest (2015) 0.77
Associations of depression diagnosis and antidepressant treatment with mortality among young and disabled Medicare beneficiaries with COPD. Gen Hosp Psychiatry (2013) 0.77
Influence of medication treatment patterns on resource use for patients hospitalized for schizophrenia. Am J Health Syst Pharm (2008) 0.77
Relationship between short-acting β2-adrenergic agonist use and healthcare costs. Am J Manag Care (2011) 0.76
Moderate symptom-based exacerbations as predictors of severe claims-based exacerbations in asthma. J Asthma (2013) 0.76
The effect of dementia on medication use and adherence among Medicare beneficiaries with chronic heart failure. Am J Geriatr Pharmacother (2012) 0.76
Sex differences in mortality following isolated traumatic brain injury among older adults. J Trauma Acute Care Surg (2016) 0.75
Risk of Stroke Among Older Medicare Antidepressant Users With Traumatic Brain Injury. J Head Trauma Rehabil (2016) 0.75
Response to Lapane and colleagues. J Am Geriatr Soc (2015) 0.75
A cross-sectional retrospective analysis of the regionalization of complex surgery. BMC Surg (2014) 0.75
Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality. Cardiol Res Pract (2009) 0.75
Perceptions of benzodiazepine dependence among women age 65 and older. J Gerontol Soc Work (2014) 0.75